HealthEquity Stock Price, News & Analysis (NASDAQ:HQY) $66.85 -0.27 (-0.40%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$66.27▼$67.4350-Day Range$64.14▼$76.1352-Week Range$48.86▼$76.62Volume516,903 shsAverage Volume654,221 shsMarket Capitalization$5.72 billionP/E Ratio445.67Dividend YieldN/APrice Target$84.14 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media HealthEquity MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside25.9% Upside$84.14 Price TargetShort InterestHealthy3.82% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.63Based on 4 Articles This WeekInsider TradingSelling Shares$4.62 M Sold Last QuarterProj. Earnings Growth40.00%From $1.35 to $1.89 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.48 out of 5 starsMedical Sector186th out of 949 stocksHealth Information Services Industry2nd out of 7 stocks 3.5 Analyst's Opinion Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $84.14, HealthEquity has a forecasted upside of 25.9% from its current price of $66.85.Amount of Analyst CoverageHealthEquity has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.82% of the outstanding shares of HealthEquity have been sold short.Short Interest Ratio / Days to CoverHealthEquity has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in HealthEquity has recently decreased by 3.25%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldHealthEquity does not currently pay a dividend.Dividend GrowthHealthEquity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HQY. Previous Next 2.6 News and Social Media Coverage News SentimentHealthEquity has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for HealthEquity this week, compared to 4 articles on an average week.Search Interest3 people have searched for HQY on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows6 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,622,991.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of HealthEquity is held by insiders.Percentage Held by Institutions98.46% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for HealthEquity are expected to grow by 40.00% in the coming year, from $1.35 to $1.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HealthEquity is 445.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 121.85.Price to Earnings Ratio vs. SectorThe P/E ratio of HealthEquity is 445.67, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 130.61.Price to Earnings Growth RatioHealthEquity has a PEG Ratio of 1.89. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthEquity has a P/B Ratio of 2.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About HealthEquity Stock (NASDAQ:HQY)HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.Read More HQY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQY Stock News HeadlinesNovember 28, 2023 | americanbankingnews.comHealthEquity (HQY) Set to Announce Quarterly Earnings on TuesdayNovember 25, 2023 | morningstar.comHealthEquity Inc HQYNovember 29, 2023 | RYSE INC. (Ad)Secure your stake in the Smart Home industry.Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.November 24, 2023 | seekingalpha.comHealthEquity: Long-Term Fundamentals Supported In Business Returns + FCF GrowthNovember 16, 2023 | money.usnews.comHealthequity IncNovember 14, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Healthequity (HQY)November 7, 2023 | finance.yahoo.comHealthEquity Named Top Workplace in Rankings NationwideNovember 6, 2023 | finance.yahoo.comWhy HealthEquity (HQY) Could Beat Earnings Estimates AgainNovember 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 3, 2023 | finance.yahoo.comDown -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)October 27, 2023 | msn.comHealthEquity Shields Investors From The Fed — And The IRS — With HSA AccountsOctober 27, 2023 | msn.comELV vs. HQY: Which Stock Is the Better Value Option?October 20, 2023 | finance.yahoo.comHealthEquity, IBD Stock Of The Day, Thrives With Fed's Higher-For-Longer RatesOctober 6, 2023 | finance.yahoo.comHealthEquity (NASDAQ:HQY) shareholders have earned a 9.8% CAGR over the last three yearsSeptember 30, 2023 | cnbc.comAs interest rates soar, buy stocks like this homebuilder, Wall Street analysts saySeptember 22, 2023 | finance.yahoo.comAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?September 21, 2023 | msn.comBaird Upgrades Healthequity (HQY)September 21, 2023 | markets.businessinsider.comBarrington Keeps Their Buy Rating on Healthequity (HQY)September 21, 2023 | msn.comHealthEquity upgraded at Baird citing tailwinds from higher ratesSeptember 21, 2023 | finance.yahoo.comUnpacking the Investment Potential of HealthEquity Inc (HQY): A Deep Dive into Key Financial MetricsSeptember 19, 2023 | finance.yahoo.comHealthEquity (HQY): A Comprehensive Analysis of Its Market ValueSeptember 19, 2023 | finance.yahoo.comHere's Why HealthEquity (HQY) is a Strong Growth StockSeptember 19, 2023 | finance.yahoo.comConduent’s BenefitWallet HSA Portfolio Moving to HealthEquitySeptember 7, 2023 | finance.yahoo.comCompany News for Sep 7, 2023September 7, 2023 | finance.yahoo.comCan HealthEquity, Inc. (NASDAQ:HQY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?September 6, 2023 | msn.comRBC Capital Maintains Healthequity (HQY) Outperform RecommendationSeptember 6, 2023 | finance.yahoo.comUnveiling the Investment Potential of HealthEquity Inc (HQY): A Comprehensive Analysis of ...See More Headlines Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/05/2023Today11/28/2023Next Earnings (Confirmed)12/05/2023Fiscal Year End1/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HQY CUSIPN/A CIK1428336 Webwww.healthequity.com Phone(801) 727-1000Fax801-727-1005Employees3,170Year FoundedN/APrice Target and Rating Average Stock Price Target$84.14 High Stock Price Target$94.00 Low Stock Price Target$72.00 Potential Upside/Downside+25.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)$0.15 Trailing P/E Ratio445.67 Forward P/E Ratio49.52 P/E Growth1.89Net Income$-26,140,000.00 Net Margins1.37% Pretax Margin1.93% Return on Equity5.08% Return on Assets3.17% Debt Debt-to-Equity Ratio0.45 Current Ratio4.09 Quick Ratio4.09 Sales & Book Value Annual Sales$937.91 million Price / Sales6.10 Cash Flow$2.65 per share Price / Cash Flow25.27 Book Value$22.40 per share Price / Book2.98Miscellaneous Outstanding Shares85,600,000Free Float83,289,000Market Cap$5.72 billion OptionableOptionable Beta0.77 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Jon Kessler (Age 55)President, CEO & Director Comp: $1.55MDr. Stephen D. Neeleman (Age 55)Founder & Vice Chairman Comp: $770.67kMr. Elimelech Rosner (Age 66)Executive VP & CTO Comp: $1.74MMr. James M. Lucania (Age 44)CFO & Executive VP Ms. Angelique Christine Hill (Age 54)Executive Vice President of Operations Mr. Richard PutnamVice President of Investor RelationsMr. Delano Ladd (Age 42)Executive VP, General Counsel & Secretary Comp: $319.48kMr. Steve LindsayExecutive Vice President of Sales & Relationship ManagementMr. Brad BennionSenior Vice President of Corporate DevelopmentMs. Tia PadiaExecutive VP & Chief Marketing OfficerMore ExecutivesKey CompetitorsGoodRxNASDAQ:GDRXNextGen HealthcareNASDAQ:NXGNIntra-Cellular TherapiesNASDAQ:ITCICRISPR TherapeuticsNASDAQ:CRSPApellis PharmaceuticalsNASDAQ:APLSView All CompetitorsInsiders & InstitutionsDeutsche Bank AGBought 6,584 shares on 11/24/2023Ownership: 0.103%Comerica BankBought 58,419 shares on 11/21/2023Ownership: 0.068%Walleye Trading LLCSold 9,700 shares on 11/21/2023Ownership: 0.000%Walleye Capital LLCSold 6,100 shares on 11/21/2023Ownership: 0.000%TimesSquare Capital Management LLCBought 11,513 shares on 11/17/2023Ownership: 0.626%View All Insider TransactionsView All Institutional Transactions HQY Stock Analysis - Frequently Asked Questions Should I buy or sell HealthEquity stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares. View HQY analyst ratings or view top-rated stocks. What is HealthEquity's stock price target for 2024? 7 Wall Street analysts have issued 1 year price targets for HealthEquity's shares. Their HQY share price targets range from $72.00 to $94.00. On average, they expect the company's stock price to reach $84.14 in the next year. This suggests a possible upside of 25.9% from the stock's current price. View analysts price targets for HQY or view top-rated stocks among Wall Street analysts. How have HQY shares performed in 2023? HealthEquity's stock was trading at $61.64 at the beginning of the year. Since then, HQY stock has increased by 8.5% and is now trading at $66.85. View the best growth stocks for 2023 here. When is HealthEquity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023. View our HQY earnings forecast. How can I listen to HealthEquity's earnings call? HealthEquity will be holding an earnings conference call on Tuesday, December 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were HealthEquity's earnings last quarter? HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Tuesday, September, 5th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.06. The firm had revenue of $243.55 million for the quarter, compared to analyst estimates of $238.89 million. HealthEquity had a net margin of 1.37% and a trailing twelve-month return on equity of 5.08%. What ETFs hold HealthEquity's stock? ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), SPDR S&P Health Care Services ETF (XHS), Global X FinTech Thematic ETF (FINX), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Nuveen Small Cap Select ETF (NSCS), Putnam Sustainable Future ETF (PFUT) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has HealthEquity issued on next quarter's earnings? HealthEquity updated its FY24 earnings guidance on Tuesday, September, 5th. The company provided earnings per share guidance of $1.97-$2.06 for the period, compared to the consensus EPS estimate of $1.93. The company issued revenue guidance of $980-$990 million, compared to the consensus revenue estimate of $981.09 million. What is Jon Kessler's approval rating as HealthEquity's CEO? 359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend. What other stocks do shareholders of HealthEquity own? Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP). Who are HealthEquity's major shareholders? HealthEquity's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (6.60%), William Blair Investment Management LLC (3.09%), JPMorgan Chase & Co. (2.72%), Clearbridge Investments LLC (2.58%), Brown Advisory Inc. (2.42%) and Allspring Global Investments Holdings LLC (1.57%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten. View institutional ownership trends. How do I buy shares of HealthEquity? Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:HQY) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthEquity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.